Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Alagille Syndrome
100%
Serum Bile Acids
100%
Liver-related Outcomes
100%
Event-free Survival
45%
Native Liver Survival
45%
Total Bilirubin
27%
Significant Predictors
18%
Liver Disease
18%
Cholestasis
18%
Inhibitor Therapy
9%
Outcome Prediction
9%
Disease Outcome
9%
First Year of Life
9%
Time-dependent Covariates
9%
Pearson Correlation
9%
Cox Regression Analysis
9%
Rare Disorders
9%
Bilirubin
9%
Total Bilirubin Level
9%
Extrahepatic Manifestations
9%
Bile Acid Levels
9%
Clinical Outcomes
9%
Ileal Bile Acid Transporter Inhibitor
9%
Bilirubin Clearance
9%
Low Serum
9%
Transporter Inhibition
9%
Ileal Bile Acid Transporter
9%
Medicine and Dentistry
Bile Acid
100%
Alagille Syndrome
100%
Event Free Survival
38%
Bilirubin
38%
Liver Disease
15%
Cholestasis
15%
Hexachlorophene
15%
Orphan Disorder
7%
Proportional Hazards Model
7%
Regression Analysis
7%
Pharmacology, Toxicology and Pharmaceutical Science
Bile Acid
100%
Alagille Syndrome
100%
Event Free Survival
38%
Bilirubin
38%
Liver Disease
15%
Hexachlorophene
15%
Cholestasis
15%
Diseases
7%
Immunology and Microbiology
Bile Acid Blood Level
100%
Event Free Survival
45%
Bile
18%